Effect of increased body mass index (BMI) on time to tumour progression (TTP) in unresectable metastatic colorectal cancer (mCRC) patients treated with bevacizumab-based therapy

[1]  J. Griggs,et al.  Appropriate Chemotherapy Dosing for Obese Adult Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline. , 2012, Journal of oncology practice.

[2]  C. Punt,et al.  Influence of body mass index on outcome in advanced colorectal cancer patients receiving chemotherapy with or without targeted therapy. , 2011, European journal of cancer.

[3]  Franck Bonnetain,et al.  Visceral fat area is an independent predictive biomarker of outcome after first-line bevacizumab-based treatment in metastatic colorectal cancer , 2009, Gut.

[4]  F. Visseren,et al.  Obesity and Cancer: The Role of Dysfunctional Adipose Tissue , 2009, Cancer Epidemiology, Biomarkers & Prevention.

[5]  J. Fenton,et al.  Novel mechanism for obesity-induced colon cancer progression. , 2009, Carcinogenesis.

[6]  J. Meyerhardt,et al.  Impact of body mass index and weight change after treatment on cancer recurrence and survival in patients with stage III colon cancer: findings from Cancer and Leukemia Group B 89803. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  W. Scheithauer,et al.  Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study , 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  E. Jung,et al.  Visceral Obesity May Affect Oncologic Outcome in Patients with Colorectal Cancer , 2008, Annals of Surgical Oncology.

[9]  M. Zwahlen,et al.  Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies , 2008, The Lancet.

[10]  M. Woodward,et al.  Obesity and Risk of Colorectal Cancer: A Meta-analysis of 31 Studies with 70,000 Events , 2007, Cancer Epidemiology Biomarkers & Prevention.

[11]  V. Beral,et al.  Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study , 2007, BMJ : British Medical Journal.

[12]  Yihai Cao.  Angiogenesis modulates adipogenesis and obesity. , 2007, The Journal of clinical investigation.

[13]  Alicja Wolk,et al.  Obesity and colon and rectal cancer risk: a meta-analysis of prospective studies. , 2007, The American journal of clinical nutrition.

[14]  Udo Hoffmann,et al.  Abdominal Visceral and Subcutaneous Adipose Tissue Compartments: Association With Metabolic Risk Factors in the Framingham Heart Study , 2007, Circulation.

[15]  N. Wolmark,et al.  Body mass index and outcomes in patients who receive adjuvant chemotherapy for colon cancer. , 2006, Journal of the National Cancer Institute.

[16]  J. Meyerhardt,et al.  Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  C. Friedenreich,et al.  Body size and risk of colon and rectal cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC). , 2006, Journal of the National Cancer Institute.

[18]  J. Baillargeon,et al.  Obesity, adipokines, and prostate cancer (review). , 2006, International journal of oncology.

[19]  P. Sucharda,et al.  Angiogenic factors are elevated in overweight and obese individuals , 2005, International Journal of Obesity.

[20]  J. Klenk,et al.  Obesity and incidence of cancer: a large cohort study of over 145 000 adults in Austria , 2005, British Journal of Cancer.

[21]  L. Belalcazar,et al.  Abdominal obesity, insulin resistance, and colon carcinogenesis are increased in mutant mice lacking gastrin gene expression , 2005, Cancer.

[22]  Tadahisa Fukui,et al.  Association of Visceral Fat Accumulation and Plasma Adiponectin with Colorectal Adenoma: Evidence for Participation of Insulin Resistance , 2005, Clinical Cancer Research.

[23]  L. Ellis,et al.  Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  K. Nakao,et al.  Leptin stimulates ischemia-induced retinal neovascularization: possible role of vascular endothelial growth factor expressed in retinal endothelial cells. , 2004, Diabetes.

[25]  J. Berlin,et al.  Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. , 2004, The New England journal of medicine.

[26]  Keith L. March,et al.  Secretion of Angiogenic and Antiapoptotic Factors by Human Adipose Stromal Cells , 2004, Circulation.

[27]  H. Bujo,et al.  Elevated serum vascular endothelial growth factor is associated with visceral fat accumulation in human obese subjects , 2003, Diabetologia.

[28]  J. Meyerhardt,et al.  Influence of body mass index on outcomes and treatment‐related toxicity in patients with colon carcinoma , 2003, Cancer.

[29]  Michael J Thun,et al.  Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. , 2003, The New England journal of medicine.

[30]  B. Lowell,et al.  Adipose tissue mass can be regulated through the vasculature , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[31]  M. Trevisan,et al.  Markers of insulin resistance and colorectal cancer mortality. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[32]  M. Thun,et al.  Body mass index and colon cancer mortality in a large prospective study. , 2000, American journal of epidemiology.

[33]  M. van Glabbeke,et al.  New guidelines to evaluate the response to treatment in solid tumors , 2000, Journal of the National Cancer Institute.

[34]  C. Dive,et al.  Obesity and cancer: Pathophysiological and biological mechanisms , 2008, Archives of physiology and biochemistry.

[35]  M. Beydoun,et al.  The obesity epidemic in the United States--gender, age, socioeconomic, racial/ethnic, and geographic characteristics: a systematic review and meta-regression analysis. , 2007, Epidemiologic reviews.

[36]  A. Bikfalvi,et al.  Tumor angiogenesis , 2020, Advances in cancer research.

[37]  M Van Glabbeke,et al.  New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. , 2000, Journal of the National Cancer Institute.